Covance

Lindevall Returns as CEO of Encorium

Friday, January 15, 2010 06:44 AM

CEO musical chairs continues at Wayne, Pa.-based contract research organization (CRO) Encorium . The company has reappointed Dr. Kai Lindevall as CEO, replacing David Ginsberg who left the company last summer when Encorium sold its U.S. business to Pierrel Research USA and Ginsberg became CEO there. Ginsberg had replaced Lindevall as CEO in September 2008. Lindevall, who replaced Kenneth Borow, M.D., as CEO in February 2008, has served as executive chairman since Ginsberg became CEO. Board member Shahab Fatheazam will serve as Encorium’s new chairman.  

More... »

Covance Opens Offices in Seoul, Mumbai

Thursday, December 17, 2009 07:42 AM

Covance recently opened new clinical development offices in Seoul, South Korea, and Mumbai, India, building on the contract research organization’s (CRO) two-decade history in the Asia-Pacific region.

More... »

Covance to Expand Food Safety Services with New Lab, Kellogg Contract

Monday, December 14, 2009 06:14 AM

Covance plans to invest $14 million in a nutritional chemistry and food safety laboratory in Michigan as part of an effort to expand the contract research organization’s (CRO’s) food safety testing capabilities. The CRO also entered into a seven-year, $42-million contract with Kellogg Company, which will be an anchor client to Covance’s new facility.

More... »

Phase Forward Q3 Revenues Jump 24%, Earnings Down by Half

Friday, October 30, 2009 09:11 AM

Waltham, Mass-based Phase Forward, a provider of data management solutions for clinical trials and drug safety, reported third quarter revenues jumped 24% to $53.1 million, compared with the third quarter of 2008, but earnings were cut in half.

More... »

Covance 3Q Revenue Up, Operating Income Down

Thursday, October 22, 2009 07:16 AM

Covance, a global contract research organization, reported third quarter revenues grew 8% to $493.7 million compared with the prior year quarter, but operating income slipped 17% to $57.8 million.

More... »

Covance Opens New Offices in Brazil and Mexico

Friday, September 25, 2009 09:36 AM

Covance opened new clinical development offices in Sao Paolo, Brazil, and Mexico City, Mexico to further expand the contract research organization’s (CRO’s) services in Latin America and increase access to patients, the company said.

More... »

Covance Expands Sleep Study Expertise

Friday, September 4, 2009 11:14 AM

Covance is expanding its capacity to support specialized sleep studies through a collaboration with Sleep Medicine Associates. 

More... »

Covance Finalizes Merck Deal, Delays Construction of Preclinical Unit

Thursday, August 20, 2009 06:35 AM

Covance officially closed a deal with Merck earlier this week to provide genomics analysis services to the drug developer for the next five years. Under the terms of the $145-million agreement, the contract research organization (CRO) acquired Merck’s Seattle-based Gene Expression Laboratory. All Merck employees related to the Seattle facility became Covance employees as of August 17.

More... »

Covance, MDS Pharma Earn MHRA Accreditation

Thursday, August 13, 2009 08:21 AM

Covance and MDS Pharma Services both recently earned standard and supplementary accreditation for the conduct of clinical pharmacology in Europe by the Medicines and Healthcare products Regulatory Agency (MHRA).

More... »

Covance Ups Guidance as Early- and Late-Stage Revenues Improve in Q2

Wednesday, July 29, 2009 08:36 PM

Covance reported an increase in both early- and late-stage drug development revenues for the second quarter of 2009 compared with the first quarter, but early-stage revenues remain significantly lower than the same period last year.

More... »